Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - large image1
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image1
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image2
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image3
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image4
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image5
Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide buy - image6

Custom Peptide Human Growth Peptide Lyophilized Powder Retatrutide Weight Loss Peptide

5936 Inquiries

Unit Price:

$90/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

gz

Brand:

DL

Packaging:

10mg/vial,10vials/box

Price valid (until):

2028-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

  • Product Description

  • Seller Information

  • History Price

  • Inquiry History

  • Description

    Name:Peach

    Whatsapp:+86 15031926308

    Email Address:sales4@xttch.com


       Product Detail  


    Retatrutide (retatrutide/retatrutide) is an innovative therapeutic drug. The following is a detailed introduction to it:

    English name: Retatrutide
    Article Title: Retarglutide/Rataglutide
    CAS number: 2381089-83-2
    Drug type: glucose-dependent otropic polypeptide (GIP)/glucagon-like peptide 1 (GLP-1)/glucagon (GCG) triple receptor agonist

    Retatrutide is a unique triple receptor agonist that can simultaneously activate the glucose-dependent otropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR).

    • GLP-1R agonism: After stimulating GLP-1R, it can promote secretion and inhibit glucagon release, thereby lowering blood sugar levels. It can also delay gastric emptying, allowing users to feel full and reduce appetite.

    • GIPR agonism: Activating GIPR can enhance the secretion of and further help lower blood sugar.

    • GCGR agonism: The agonistic effect on GCGR can promote fat decomposition and energy metabolism, which helps achieve weight loss goals. This multiple mechanism of action works together to make Retatrutide show great potential in weight management, blood sugar control, and overall metabolic health regulation.

    Items Specifications
    Product Name Retatrutide
    Other Name LY3298176
    Appearance White power
    Specification 5mg 10mg 15mg 20mg 30mg
    Purity >99%


    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 1


    Mechanism of action


    Mechanism of action

    • GLP-1R agonism: Stimulation of GLP-1R can promote secretion and inhibit glucagon release, thereby lowering blood sugar levels. It can also delay gastric emptying, making users feel full and reducing appetite.

    • GIPR agonism: Activating GIPR can enhance the secretion of and further help lower blood sugar.

    • GCGR agonism: The agonism of GCGR can promote fat decomposition and energy metabolism, which helps achieve weight loss goals. This multiple mechanism of action works together to make Retatrutide show great potential in weight management, blood sugar control and overall metabolic health regulation.

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 2


      Clinical trial results  


    Clinical trial results

    Weight loss effect: In phase 2 clinical trials, Retatrutide demonstrated significant weight loss effects. Obese patients lost more than 24% of their body weight after 48 weeks of treatment with Retatrutide. Among them, patients taking 8mg and 12mg doses lost at least 5% of their weight, and the weight loss effect of the high-dose group (12mg) was more significant.
    Hypoglycemic effect: After 6 months of treatment with different doses of Retatrutide in patients with type 2 diabetes, glycated hemoglobin (HbA1c) decreased by 1.3%\~2.0%.
    Safety: The safety and tolerability profile of Retatrutide is similar to other receptor agonists. The most common adverse reactions are gastrointestinal reactions, such as nausea, diarrhea, vomiting and constipation, mostly mild to moderate. In addition, some patients experience symptoms of increased heart rate, but this usually resolves after 24 weeks.

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 3


      Product Detail  


    Scope of application
    Obesity treatment: As an auxiliary treatment to diet control and exercise, it is used for long-term weight management in adults who are obese or overweight and have at least one weight-related comorbidity.
    Type 2 diabetes treatment: Helps patients with type 2 diabetes lower blood sugar and lose weight at the same time.

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 4


    Storage conditions


    Storage conditions
    Low temperature, non-hazardous chemical shipments.
    Packed to the nearest milligram upon request.
    It is recommended to store sealed and away from light at 2~8°C, and refrigerated at -15~0°C for long-term storage.

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 5


      Product packaging


    5mg/vial,10vials/box;

    10mg/vial,10vials/box;

    15mg/vial,10vials/box;

    60mg/vial,10vials/box;

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 6

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 7 Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 8 Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 9


      logistics  


    Customers can specify express delivery, such as: UPS/DHL, etc. (Default express delivery: our cooperative logistics company)

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 10


    Company Profile


    Changsha Duole Technology Co., Ltd.,  located in Changsha City, Hunan Province, is a high-tech enterprise focusing on the research, development and production of peptide products. The company was established in recent years and is committed to applying advanced biotechnology to the health industry to meet the market's demand for high-quality, high-efficiency peptide products.
    As a leading peptide manufacturer, Dole Technology has a R&D team composed of senior scientists and engineers, which continues to explore and innovate, and is committed to developing safer, more effective, and more market-competitive peptide products. The company's main products cover but are not limited to pharmaceutical grade, food grade and cosmetic grade and other fields, and are widely used in many aspects such as health care, disease prevention, beauty and skin care.

    In terms of production technology, Dole Technology adopts internationally advanced production equipment and technology to ensure that every aspect of the product, from raw material selection, production and processing to finished product packaging, strictly follows relevant national standards and specifications to ensure product quality and safety. At the same time, the company has also established a complete quality management system and after-sales service system to provide customers with all-round, one-stop service support.
    Duole Technology adheres to the corporate philosophy of "technology leads health, quality creates the future" and always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills its social responsibilities and is committed to promoting the development and progress of the health industry.

    In the future, Changsha Duole Technology Co., Ltd. will continue to delve into the field of peptide product research and development, continue to explore and make breakthroughs, and strive to become a leader in the global peptide industry and make greater contributions to human health.

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 11


      Why choose us?


    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 12

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 13

    Shop Cagrilintide Lyophilized Powder CAS 2381089-83-2 Retatrutide Therapy Kits Liraglutide Weight Loss Peptide-Detailed Image 14




    Come and contact me~  


    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    LY3437943;Retatrutide;GIPR/GLP-1R;Retatrutide/LY3437943/GIPR/GLP-1R;Retaglutide;Retatrutide acetate;LY3437943Retatrutide;Retalutide

    CAS No.:

    2381089-83-2

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

    Location:

    Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

    Average lead Time:

    2

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Changsha Duole Technology Co., Ltd

    Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    5936 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.